LIVE TV
ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Budget 2021
  • Personal Finance
    • PPF
    • Mutual Funds
    • Income tax
    • EPFO
    • Income Tax Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • Home Loan Calculator
    • SIP calculator
    • SWP Calculator
    • MF Returns Calculator
    • Lumpsum Calculator
  • India
    • Companies
    • Property
    • Startups
    • Uidai
  • Economy
    • Aviation
  • Tech
    • Mobiles
    • Apps
  • Auto
    • Cars
    • Bikes
  • Markets
    • Commodities
    • Currency
  • Jobs
  • Indian Railways
  • World
    • Economy
    • Politics
    • Markets
  • videos
  • photos
  • Authors
  • More ...
    • VIDEOS
    • PHOTOS

Read in App
Business News » World News

GSK puts old antibiotics and UK Horlicks business on the block

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
Updated: Wed, Jul 19, 2017
06:54 pm
Reuters

GlaxoSmithKline said it was considering the sale of its cephalosporins antibiotics business and intended to divest its small Horlicks business in Britain, while retaining the much bigger malted drink operation in India.

The antibiotics business under strategic review covers the brands Zinnat/Ceftin, Zinacef and Fortum and has worldwide annual sales estimated at around 200 million pounds ($260 million), but it faces growing competition from cheap generics.

In addition, GSK announced just over 300 job losses on Wednesday and confirmed that the UK-focused MaxiNutrition sports nutrition brand would be sold.

The combined annual UK sales of Horlicks and MaxiNutrition, which industry sources had previously said were on the block, are around 30 million pounds. GSK is also exploring options to divest some other smaller non-core nutrition brands.

The moves show new Chief Executive Officer Emma Walmsley putting her mark on Britain`s biggest drugmaker as she tries to simplify operations, improve operating efficiencies and focus on priority areas.

She will outline her wider vision for GSK alongside half-year results next week.

The company said in a statement that none of the changes had been taken as a result of Britain`s decision to leave the European Union.

Although GSK will continue to make other antibiotics, such as Augmentin, and will conduct research into new medicines to fight so-called superbug infections, it will no longer need as many factories.

As a result, it has decided not to proceed with a previously planned 350 million pounds investment to build a new facility in Ulverston, northern England, and it will outsource some manufacturing work at its Worthing site on the south coast.

The cuts at Worthing and at a factory in Slough, where Horlicks is made, will result in around 320 job losses over the next four years. Overall, GSK employs 17,000 staff in Britain, with 5,000 in manufacturing, and it plans to invest more than 140 million pounds at other UK sites between now and 2020.

In Britain, where Horlicks is sold as a bedtime drink, the product has largely fallen out of favour and sales are very limited. Indian demand for Horlicks, by contrast, is strong and GSK has developed the malted barley milk drink into its top consumer brand in the country.

Selling both MaxiNutrition, which GSK bought for 162 million pounds ($210 million) in 2010, and the British arm of Horlicks, which is an even smaller business, will not move the dial at the drugmaker, given its market value of 79 billion pounds.

Horlicks is more than 140 years old with origins dating back to 1873, when two British-born men, James and William Horlick, first founded a company in Chicago to manufacture the drink.

($1 = 0.7672 pounds)

(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:

LATEST NEWS

Anil Singhvi’s Strategy January 22: Day support zone on Nifty is 14,475-14,525 & Bank Nifty is 31,900-32,000

HISTORIC! Sensex at WHOPPING 50,000-pt all-time high! Know journey from 100-pt level with Anil SInghvi

Twitter restarts Biden''s @POTUS account with zero followers

Bajsons Shirts – A Brand That Believes In Nurturing The People Connect

Banks sanction additional Rs 15,571 cr to MSMEs under ECLGS 2.0

Income Tax returns: Earning money from YouTube, Facebook, Twitter? MUST know this Social Media ITR filing rule

Gold Price Today 21 January 2021 – Gold gains by Rs 200 in morning trade, Silver price stronger by Rs 740; Expert recommends BUY!

Budget 2021 Markets Want More: How FM Sitharaman can make investments more attractive - Expert Deepak Jasani explains

Stocks in Focus on January 22: Indigo Paints IPO, Biocon, Indian Energy Exchange, InfoEdge to Asian Paints; here are the 5 Newsmakers of the Day

State of the economy: What will 2021 look like? Good news for India! Positive growth - Check what RBI bulletin confirmed

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
Copyright © Zee Media Corporation Ltd. All rights reserved